How much is Paradox Immunotherapeutics worth in 2026?

Paradox Immunotherapeutics has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Paradox Immunotherapeutics raised?

Paradox Immunotherapeutics has raised $10.0M in total funding across 1 funding rounds.

Paradox Immunotherapeutics

Drug DiscoveryWebsite

Paradox Immunotherapeutics valuation and funding history | Last updated: February 25, 2025 | 1 funding rounds

Current Valuation

N/A

As of February 25, 2025

Total Funding Raised

$10.0M

Across 1 round

Last Round

Later Stage VC

$10.0M

Last Funding

Feb 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 1, 2022	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Paradox Immunotherapeutics is currently valued at N/A as of February 25, 2025. The company has raised a total of $10.0M in funding across 1 funding round.

Track Paradox Immunotherapeutics Valuation Updates

Get notified when Paradox Immunotherapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Paradox Immunotherapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Paradox Immunotherapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Paradox Immunotherapeutics Worth in 2026?

Paradox Immunotherapeutics is a leading private company in the Drug Discovery sector. Track Paradox Immunotherapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Paradox Immunotherapeutics Valuation is Determined

Private company valuations like Paradox Immunotherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.